Explore the comprehensive guide to ICH E2A, a vital pharmaceutical guideline for expedited reporting of adverse drug reactions during clinical trials. Learn about its historical background, key components, global impact, and how it contributes to patient safety. Stay informed on updates, revisions, and the significance of risk-benefit assessment in clinical development.
- Home Posts tagged "guideline updates"